The Do’s & Don’ts of Multi Channel Implementation
Reactions
(8)
No comment yet.
Sign up to comment
Trois questions à Dominique Noël, présidente du Festival de la Communication Santé #FCsanté #placetogo
Ce rendez-vous incontournable des acteurs clés de ce secteur attire de plus en plus de professionnels de santé, médecins, pharmaciens, paramédicaux et leurs représentants tous impliqués dans ces initiatives et ces campagnes. Dominique Noël, présidente du Festival dévoile de nouvelles perspectives dans ce secteur.
#Hacktioncontrelecancer : entre tendances et convergences pour améliorer la communication patient/soignant en cancer #hcsmeufr #esante #pharma
Lionel Reichardt / le Pharmageek:
#Hacktioncontrelecancer : entre tendances et convergences pour améliorer la communication patient/soignant en cancer #hcsmeufr #esante #pharma
Loi « anti-cadeaux » : le secteur de la santé toujours dans l’incertitude !
Sébastien Pradeau, spécialiste du droit de la santé et Of Counsel au sein du cabinet Fieldfischer, nous signale que le Sénat a ratifié 4 ordonnances prises en application de la loi de modernisation…
The pharma industry can’t fix its reputation until it honestly faces up to its problems. Is it time for an industry ethical code? #hcsmeufr #esante #digitalhealth
In many ways, the pharma industry deserves its bad press. But treating the industry as a single, unified entity is unfair to the many ethical companies that wouldn’t dream of price gouging. However, I think that lobby groups (for example, the Association of the British Pharmaceutical Industry, the European Federation of Pharmaceutical Industries and Associations, and the Pharmaceutical Research and Manufacturers of America) are doing the industry a disservice by defending unethical behavior. Of course, the industry does a lot of good, but we must acknowledge and take action against the bad. It is for this reason that I have set out to develop an ethical code for the pharma industry.
4 best channels to communicate with physicians
Pharmaceutical representatives have a tough job on their hands. They have to convince doctors that the products they’re selling are worth physicians’ time and patients’ money. This is no easy feat, especially when considering the busy schedules medical professionals keep and their limited time to speak with drug reps.
To be respectful of physicians’ packed calendars, while also ensuring these healthcare providers have the information and access to helpful pharmaceutical medications, representatives have to do more than show up at a doctor’s office to showcase their products.
Here are four of the best channels you can use to communicate effectively and efficiently with busy physicians:
1. Email
According to HealthLink Dimensions’ 2017 Healthcare Provider Communication Survey, around 66 percent of physicians consider email to be their preferred means of interaction when it comes to information related to product updates or announcements. As a result, it’s critical for drug representatives to use this tactic to communicate with their audience. But simply sending an email isn’t enough. Pharmaceutical companies also need to make sure their efforts are optimized to be read on a variety of devices, from desktop computers to mobile phones and tablets. This ensures doctors will be able to look over the product materials on their smart instruments during any down time or breaks they have during the day.
2. Professional conferences
When physicians do get some quality time off from their practice, they may use it to further improve the services and products their office provides patients. Professional conferences enable doctors to gather a wealth of information while also attending helpful talks related to their craft. These conferences provide face-to-face time with doctors who are interested in learning more about what’s on the market for the benefit of their patients. Just be sure your presentation is short and sweet, keeping the most important data points at the top of the discussion to keep physicians’ interest. In addition to an exhibit hall area, conferences provide ample opportunities to network with healthcare professionals, such as continuing educational sessions and association sponsored social events. Sometimes some of the smaller, regional meetings provide a better chance to network with healthcare professionals in your area. To help you find some meetings you may have not attended before, here’s a source to search over 2500 medical meetings by destination and specialty.
3. Direct mail
Direct mail will never go out of practice and for good reason: It still works. Sending out brochures, catalogs, postcards and other promotional materials is a good way to market medications, especially if free samples are included for physicians to test out with their patients. According to the HealthLink survey, 8 percent of physicians prefer this advertising tactic. To ensure your direct mail campaign is successful, Target Marketing recommended:
- Focusing on the benefits of the pharmaceutical drugs.
- Integrating direct mail with other marketing methods.
- Repurposing content frequently.
- Regularly updating recipient lists.
- Creating personal outreach.
- Following up after the fact.
By following these tips, pharmaceutical companies and their representatives can yield strong results.
“Marketers should form quality relationships with their audience via social media.”
4. Social media
Today, around 37 percent of physicians use social media platforms to communicate with patients, other doctors and healthcare professionals, and pharmaceutical and medical device companies, according to HealthLink. On top of that, almost 57 percent of doctors see the value of this practice and plan to utilize it in the future.
Social media is an easy and inexpensive way to get the word out about new pharmaceutical medications and more. The platforms are free to sign up for, but do offer buy-in features for companies to enhance their marketing pull and audience. In order to make this tactic a success, it’s important for pharma representatives to build quality relationships with those individuals they interact with, according to Social Media Examiner. Those who see the benefit in their interactions with pharma companies on these platforms are more willing to share information and bring referrals to the site.
While representative visits to doctor’s offices can be productive, more and more physicians are instituting “No See” days where they don’t allow pharma companies into their facility. To ensure medical professionals still have access to important drug information and updates, these organizations need to utilize other forms of marketing, including email, conference exhibits, direct mail and social media.
Since the majority of these alternative methods require physician materials to be successful, it’s important for pharma businesses to ensure the data they have on hand is accurate and up to date. Without clean information, marketers can waste valuable time and money on their efforts.
#HacktionContreLeCancer : un hackathon par @AmgenFrance #esante #hcsmeufr
#HacktionContreLeCancer un hackathon du laboratoire Amgen pour améliorer la communication patient/soignant en oncologie. Retrouvez les projets là
Lionel Reichardt / le Pharmageek:
#HacktionContreLeCancer un hackathon du laboratoire Amgen pour améliorer la communication patient/soignant en oncologie. Retrouvez les projets là
How Patient Portals Improve Patient Engagement #digitalhealth #hcsmeufr #esante
Patient portals are a regularly talked-about technology in a doctor's tool belt, but how can they use the portal to boost patient engagement?
Janssen makes iSTEP clinical trials digital platform open to all #digitalhealth #hcsmeufr #esante
Janssen's new iSTEP platform integrates mobile technology, 'smart' blister packs of pills and electronic labelling to improve adherence.
Digital Marketing for Healthcare Industry
Presentation on Digital Marketing for Healthcare Industry, that I delivered at Goa Institute of Management.
Santé : comment la France peut prendre un leadership européen #hcsmeufr #esante
La France revient au premier plan sur la scène internationale avec déjà des signes tangibles d’un
Les industries de santé réclament des réformes structurelles plutôt que des coups "de rabot"
Le lobby veut renforcer ses relations avec les pouvoirs publics pou
FDA Approval of HIV Medicines #sansrepit cc @leemfrance
A timeline with all the FDA approval dates for HIV medicines, categorized by drug class.
Dr Belinda Chaplin's curator insight,
October 10, 8:17 PM
HIV pharmocology products over time...the evidence changes
FDA picks big tech and pharma for digital health fast-track - Pharmaphorum
Apple, Fitbit, Samsung and Verily will join Johnson & Johnson and Roche as part of the FDA digital health pilot pre-certification programme.
Survey: pharma not helping online health info seekers - Pharmaphorum
The results of exclusive research with people seeking health information online in the US, UK and Canada should be a wake-up call for pharma, says Richard Meyer.
The results of a recent survey with over 16,000 people looking for health-related information suggest that pharma companies need to review their digital marketing capabilities. The data come from research with responders in the US (n = 9,544), UK (n = 3,674) and Canada (n = 3,285).
Here are some topline findings.
(1) Regarding the search for online health information, most were confused with the depth of information found and spent a lot of time trying to better understand and confirm it. Among the key complaints were that health information was too hard to understand and that some of the information was outdated.
(2) Pharma product websites were only seen as resources for the drug, not as resources for health information. In addition pharma companies did not update their content enough, especially when treatments were in the news.
(3) The number one online site mentioned was WebMD but the vast majority of respondents (71%) said they went to multiple websites to get all the information they needed.
(4) Social media was becoming more important in the search for online health information, with people looking for information on the experiences of others with certain treatments, along with ways to save money and work with their insurance companies to get a prescribed/recommended treatment.
(5) Women went online for health information more than men, although they only went online when there was a trigger (i.e. upcoming appointment with doctor, or diagnosis).
(6) Respondents did go to pharma websites to review medications, but also went to competitors’ sites. Their choice of treatment was often based on cost and benefit versus side effects, as it related to quality of life.
(7) Even though direct-to-consumer (DTC) advertising is not permitted in the UK or Canada, online health information seekers still used the Internet to visit pharma websites. (...)
Some of the (US) respondents were chosen for an in-depth follow-up conversation via phone call to better understand their biggest concerns with healthcare. The US respondents’ number one concern was the rising cost of health insurance, with a majority saying that it was eating into their compensation. In fact, some said that they wouldn’t leave their current employer because they were afraid of either losing insurance or paying more for it with a potential new employer.
In probing this issue to better understand attitudes towards insurers, people were happy to expand on this subject. Essentially, they felt that their health insurers were not treating them like customers and were dictating treatments too much. For example, one woman had to wait 60 days to try a new multiple sclerosis treatment, which meant she had have 60 days without any treatment. “I’m the customer,” she said. “What the hell am I paying you for?”
The biggest frustration with the US healthcare system was the inability to share medical records with a variety of physicians. Patients believed that their medical records were THEIR property and wanted them to follow them if they moved location or visited specialists.
In Canada respondents reported that the overriding issue was the time it could take to see a specialist, which could be weeks or months. Some said that they had crossed the border into the US in order to see a specialist sooner.
The moderator for this research and our data analysts consistently observed that “people seem to be getting lost in the search for healthcare information” and that they “often look to their doctor to help them sort it out”. They felt as though they were not visible in a system that, they felt, treated them as a number rather than as a person who had a lot of questions and anxiety...
rob halkes's curator insight,
October 9, 8:56 AM
Current market conditions, both in US, Canad and UK, show how the developments in healthcare emerge more quickly than pharma companies are able to follow up. Here's a research telling how patients experience difficulties to find information on thier health conditions and about their own health. They must feel as being a number not recognized for their intent to seriously understand what their condition is all about and how to cope. It also appears that pharma is not the only stakeholder that lacks behind patient engagement: healthcare insurances as well as health provider institutes ignore or even willfully sustain barriers for patient to learn for themselves and do something about their own condition. It's no wonder so, that health care costs keep on rising!
Accès aux Médicaments : le classement 2016 des laboratoires pharmaceutiques MyPharma Editions | L'Info Industrie & Politique de Santé
Publié le mardi 15 novembre 2016
L’Indice d’Accès aux Médicaments (Access to Medicines Index) 2016, publié lundi, établit un classement des 20 principaux laboratoires pharmaceutiques en fonction des efforts qu’ils accomplissent afin d’améliorer l’accès aux médicaments dans les pays à faibles et moyens revenus. GSK arrive en tête du classement pour la 5ème fois suivi par un groupe compact comprenant Johnson & Johnson, Novartis et Merck KGaA.
Cet indice est publié tous les deux ans par l’Access to Medicine Foundation, un organisme indépendant à but non lucratif financé par la Fondation Bill et Melinda Gates, le Ministère Néerlandais des Affaires Étrangères et le Département pour le Développement International du Royaume-Uni.
Cet indice classe les laboratoires « en fonction de leurs efforts d’amélioration de l’accès aux médicaments, l’évaluation portant sur sept domaines comportementaux. Il identifie les meilleures pratiques, met en lumière les domaines faisant l’objet d’améliorations et ceux dans lesquels des actions importantes restent nécessaires », précise l’Access to Medicine Foundation.
Médicaments : le prix a aussi un impact sur l’effet nocebo
Plus un médicament est coûteux, plus le risque d’effets indésirables « imaginaires » serait grand.
Un médicament sans principe actif peut parfois se révéler très efficace… pour peu que le malade soit convaincu de son efficacité. C’est ce qu’on appelle communément l’effet placebo. Le «bisou magique» donné aux enfants pour soulager leur douleur après un bobo en est un bon exemple. L’homéopathie en est un autre. Mais il existe également une face obscure de l’effet placebo, moins connue du grand public: l’effet nocebo. Il survient quand une personne ressent des effets secondaires lorsqu’on lui administre un médicament sans principe actif ou que son état se détériore parce qu’elle doute de l’efficacité de son traitement.
Patient Engagement Strategies for Young, Healthy Populations
Patient engagement strategies for young and healthy populations should include technology to drive personal and convenient care.
#SansRépit : nouvelle campagne grand public du Leem
Le Leem a lancé une campagne de communication grand public sur les traitements en cours de développement au sein des entreprises du médicament.
Cancer : les nouveaux médicaments seraient peu efficaces
L'évaluation des 48 médicaments mis sur le marché entre 2009 et 2013 montre que peu de molécules améliorent la qualité de vie et la survie des malades.
La transformation numérique des entreprises s'accélère avec les CDO - Business Analytics Info
Un nombre croissant de grandes entreprises recourent à un « Chief Digital Officer » pour mener à bien leur transformation numérique
Le 39bis, un laboratoire de Sanofi 100 % e-santé - Juin 2017 - Pharmaceutiques
Sanofi investit dans le domaine du digital depuis plusieurs années, avec comme premier succès Diabeo. Nouvelle étape en fin d’année avec la création d’un laboratoire d’open-innovation entièrement dédié à la e-santé.
Hackathon Amgen : Hack’tion Contre le Cancer 48h pour relever le défi de la communication patients soignants #hacktioncontrelecancer #hcsmeufr
#HacktionContreLeCancer 29-30 septembre et 1er Octobre 2017
Lionel Reichardt / le Pharmageek:
Hackathon Amgen : Hack’tion Contre le Cancer 48h pour relever le défi de la communication patients <-> soignants #hacktioncontrelecancer #hcsmeufr
InCrowd Survey: For Healthcare News, Physicians Most Frequently Turn to Social Media
A recent study from the Pew Research Center indicated that over 67% of Americans look to social media sites for breaking news stories. With the ever-changing US healthcare system a constant focus of the 24-hour news cycle, we asked our Crowd about their primary resources for the latest healthcare information. InCrowd’s MicroSurvey tool reached out to 150 US-based physicians from a variety of specialties, averaging 15 years in practice and 44 years of age, to gather their input on where they are getting their healthcare news
Approximately 62% of practitioners’ prefer online news sources, including internet articles and video clips, news apps, and/or social media. Only 8% referenced a desire for traditional news sources such as hardcopy newspapers or television.
Consistent with the Pew study, social media news stood out in particular when physicians reported the frequency of their engagement. 51% of physicians refer to social media sites 3 or more times a week, where only 13% maintain similar engagement with news apps and other online resources. Interestingly, almost 30% of respondents reported checking their social media 7 or more times a week to stay up to date on healthcare topics.
Social media has become an extremely effective medium to reach physicians and the internal health care industry is taking notice. Organizations such as the American Academy of Family Physicians and the American Medical Association utilize a “broadcast” setting on Twitter and hosting Facebook live events. Longstanding organizations are actively pursuing these non-traditional methods to inform healthcare audiences antiquated hard copy news sources.
While many physicians seem fairly interested in utilizing social media to gain news updates, other have a hesitancy to use public social media platforms regularly due to concerns over privacy and uncontrolled patient interaction. Look for more in our upcoming blogs regarding the opportunities and risks of social media for the healthcare professional community.
Vivre avec la FPI : nouveau site web par Boehringer Ingelheim
Boehringer Ingelheim a lancé un site web dédié aux personnes atteintes de fibrose pulmonaire idiopathique (FPI) et leur entourage : « Vivre avec la FPI».
Your new post is loading...
